Allarity Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Allarity Therapeutics Total Assets Growth & History (ALLR)
Allarity Therapeutics's total assets was $18.3M for fiscal 2025.
View full Allarity Therapeutics company overviewAllarity Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $18.3M | −$4.4M | −19.39% |
| 2024 | 2024-12-31 | $22.6M | $10.8M | +90.95% |
| 2023 | 2023-12-31 | $11.9M | −$2.7M | −18.44% |
| 2022 | 2022-12-31 | $14.5M | −$35.1M | −70.70% |
| 2021 | 2021-12-31 | $49.6M | $16.2M | +48.59% |
| 2020 | 2020-12-31 | $33.4M | — | — |
Allarity Therapeutics quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $32.1M | $10.9M | +51.45% |
| Q1 2026 | 2026-03-31 | $34.9M | $5.2M | +17.47% |
| Q4 2025 | 2025-12-31 | $18.3M | −$4.4M | −19.39% |
| Q3 2025 | 2025-09-30 | $20.8M | $418,000 | +2.05% |
| Q2 2025 | 2025-06-30 | $21.2M | −$9.7M | −31.34% |
| Q1 2025 | 2025-03-31 | $29.7M | $17.8M | +148.39% |
| Q4 2024 | 2024-12-31 | $22.6M | $10.8M | +90.95% |
| Q3 2024 | 2024-09-30 | $20.4M | $6.5M | +46.87% |
| Q2 2024 | 2024-06-30 | $30.9M | $17.5M | +130.02% |
| Q1 2024 | 2024-03-31 | $12.0M | −$733,000 | −5.77% |
| Q4 2023 | 2023-12-31 | $11.9M | −$2.7M | −18.44% |
| Q3 2023 | 2023-09-30 | $13.9M | −$4.3M | −23.49% |
| Q2 2023 | 2023-06-30 | $13.4M | −$9.8M | −42.21% |
| Q1 2023 | 2023-03-31 | $12.7M | −$18.6M | −59.41% |
| Q4 2022 | 2022-12-31 | $14.5M | −$35.1M | −70.70% |
| Q3 2022 | 2022-09-30 | $18.1M | −$18.9M | −50.97% |
| Q2 2022 | 2022-06-30 | $23.2M | — | — |
| Q1 2022 | 2022-03-31 | $31.3M | — | — |
| Q4 2021 | 2021-12-31 | $49.6M | $16.2M | +48.59% |
| Q3 2021 | 2021-09-30 | $37.0M | — | — |
| Q4 2020 | 2020-12-31 | $33.4M | — | — |
Allarity Therapeutics total assets trends
Over the last five fiscal years, Allarity Therapeutics's total assets decreased from $33.4M to $18.3M, a change of −$15.1M. The latest reported quarter, Q2 2026, shows $32.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Allarity Therapeutics source filings ↗